| COMPOSITON | |
|---|---|
| PANTOPRAZOLE | 40 MG |
pantoprazole
PANTAVIB / PANTOFEC
| SPECIFICATION | ||
|---|---|---|
| FORM | TABLET | INJECTABLE |
| PACKING | 10X10 | – |
| PACKING TYPE | ALU ALU | – |
| MRP | 830 | 45.24 |
ALSO AVAILABLE
SIMILAR PRODUCTS
INDICATION
Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
SIDE EFFECTS
Short-term (up to 16 weeks) treatment of erosive esophagitis.
INDICATION
Single intravenous doses of pantoprazole at 378, 230, and 266 mg/kg (38, 46, and 177 times the recommended human dose based on body surface area) were lethal to mice, rats and dogs, respectively. The symptoms of toxicity included hypoactivity, ataxia, hunched sitting, limb-splay, lateral position, segregation, absence of ear reflex, and tremor. There is limited experience regarding cases of human overdosage, and treatment should be symptomatic and supportive.